Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Medi-Fare Drug
WARNING LETTER
•Medi-Fare Drug•January 18, 2013

Medi-Fare Drug – FDA Warning Letter, Jan 18, 2013

Record Details

On December 10, 2012, to January 18, 2013, the FDA inspected Medi-Fare Drug & Home Health Center, Inc., observing significant violations. The firm produced drug products without valid prescriptions for individually-identified patients and exhibited serious deficiencies in sterile drug product manufacturing, risking contamination. These issues were noted on an FDA Form 483.

The FDA held a teleconference on February 28, 2013, expressing concerns about the aseptic fill area's design, which was (b)(4) and used for non-sterile activities, increasing contamination risk. The firm agreed not to resume sterile drug production until corrective actions were implemented.

The firm's drug products, produced without individual prescriptions, do not qualify for exemptions under section 503A of the FDCA or FDA's Compliance Policy Guide 460.200. Consequently, these drugs are unapproved new drugs and misbranded, violating sections 505(a) and 502(f)(1) of the FDCA.

Furthermore, the firm's manufacturing practices violate Current Good Manufacturing Practice (CGMP) regulations (21 CFR Parts 210 and 211), rendering the drugs adulterated under section 501(a)(2)(B) of the FDCA. Specific CGMP violations include: 1. Failure to establish adequate air supply and

Company
Medi-Fare Drug
Inspection date
January 18, 2013
Product type
Drugs
Office
Atlanta District Office
Person
  • John R. Gridley
View Company Profile

ID · fbd734e8-c2e1-4431-b9eb-94613341af89

Violation Codes10
21 U.S.C. 321(g)21 U.S.C. 353a21.U.S.C. 355(a)21 U.S.C. 352(f)(1)21 U.S.C. 331(d)21 U.S.C. 321(p)21 CFR 21021 CFR 21121 CFR 211.42(c)(10)(iii)21 CFR 211.113(b)

Full citation text and observation details available on the Dashboard.

Other documents for Medi-Fare Drug
  • 483 - 2025-06-07June 7, 2025
  • 483 - 2023-05-26May 26, 2023
  • 483 - 2014-09-12September 12, 2014
  • 483 - 2013-06-21June 21, 2013
  • 483 - 2013-01-18January 18, 2013

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Medi-Fare Drug
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.